2021
DOI: 10.1002/mgg3.1631
|View full text |Cite
|
Sign up to set email alerts
|

Mutational spectrum of NF1 gene in 24 unrelated Egyptian families with neurofibromatosis type 1

Abstract: is a progressive genetic disease characterized by a neuroectodermal abnormality, mainly affecting the skin, nervous system, bones, eyes, and possibly other organs. This disorder has been divided into three forms: Neurofibromatosis type 1, Neurofibromatosis type 2, and Shwannomatosis (Jett & Friedman, 2010).Neurofibromatosis 1 (NF1; OMIM# 162200) is one of the most common autosomal dominant genetic diseases with a worldwide incidence of about 1:3500 (Jett & Friedman, 2010;Mao et al., 2018). In 95% of cases, cli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
8
0
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 69 publications
2
8
0
2
Order By: Relevance
“…In these patients, the clinic was mild, and skin findings (CALs, freckling, and neurofibromas), Lisch nodules were prominent. Also, a milder form of the disease, characterized by the presence of only CALs and freckles, with changes in the amino acid found in p.Arg1809, has been reported in the literature (13). CAL is the most common feature in NF1.…”
Section: Discussionmentioning
confidence: 91%
See 4 more Smart Citations
“…In these patients, the clinic was mild, and skin findings (CALs, freckling, and neurofibromas), Lisch nodules were prominent. Also, a milder form of the disease, characterized by the presence of only CALs and freckles, with changes in the amino acid found in p.Arg1809, has been reported in the literature (13). CAL is the most common feature in NF1.…”
Section: Discussionmentioning
confidence: 91%
“…Nevertheless, 38.4 % (n:15) of the variations were familial, while 43.5% (n:17) were de novo variations. (2,12,13). Worldwide, DNA mutations in NF1 are responsible for 88-97% of clinically diagnosed NF1 cases.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations